IGFBP-5
IGFBP-5 (insulin-like growth factor-binding protein 5) is a multifunctional secreted protein that regulates how much IGF is available to its receptors. It also acts independently of IGFs, influencing bone formation, extracellular matrix deposition and receptor signalling. Browse Assay Genie's current range of IGFBP-5 research reagents below, or read on for the biology behind the target.
IGFBP-5 is a multifunctional protein that plays a critical role in regulating the availability of IGFs to their receptors. Through this control it shapes IGF-mediated cellular processes, including proliferation, differentiation and apoptosis, in a cell-type specific manner. It increases the proliferation of osteoblasts, intestinal smooth muscle cells and neuroblastoma cells. It enhances adhesion and survival of epithelial cells but decreases adhesion of mesenchymal cells. Once secreted, it acts as a major mediator of mTORC1-dependent feedback inhibition of IGF1 signalling.
IGFBP-5 also has activities that do not depend on IGF binding. It contributes to the induction of extracellular matrix (ECM) production and deposition independently of its nuclear translocation and binding to IGFs. It can act as a growth factor in its own right, regulating bone formation independently of IGFs. It is also a ligand for the ROR1 receptor, which triggers formation of a ROR1/HER2 heterodimer and enhances CREB oncogenic signalling. The protein is found as a secreted form and in the cytoplasm and nucleus. NCBI Gene annotation lists IGF-I binding and receptor ligand activity, and describes the protein as part of the insulin-like growth factor ternary complex.
The IGFBP5 gene belongs to the HGNC group of insulin like growth factor binding proteins, which includes IGFBP-1 to IGFBP-4, IGFBP-6 and IGFBP-7. Mouse and rat both carry an orthologous Igfbp5 gene. According to NCBI Gene, IGFBP-5 is involved in cellular response to cAMP and in regulating smooth muscle cell migration and proliferation, and it is described as a biomarker of pulmonary fibrosis. Researchers studying the IGFBP-5 protein often use it to examine IGF signalling, ECM biology and bone regulation.
IGFBP-5 controls the availability of IGFs to their receptors and mediates mTORC1-dependent feedback inhibition of IGF1 signalling.
IGFBP-5 increases osteoblast proliferation and can act independently of IGFs as a growth factor regulating bone formation.
IGFBP-5 helps induce extracellular matrix production and deposition, and is described as a biomarker of pulmonary fibrosis.
As a ROR1 ligand, IGFBP-5 triggers ROR1/HER2 heterodimer formation and enhances CREB oncogenic signalling.
IGFBP-5 regulates the availability of IGFs to their receptors, and so influences IGF-mediated proliferation, differentiation and apoptosis in a cell-type specific manner. It also acts independently of IGFs, promoting ECM deposition, regulating bone formation and serving as a ligand for the ROR1 receptor.
UniProt lists IGFBP-5 as secreted, cytoplasmic and nuclear. The HGNC gene symbol is IGFBP5, and the earlier name was insulin-like growth factor binding protein 5. No other aliases or previous symbols are recorded. It belongs to the insulin like growth factor binding protein group.
Mouse and rat each have an orthologous Igfbp5 gene. NCBI Gene describes IGFBP-5 as a biomarker of pulmonary fibrosis, and UniProt notes ROR1-mediated enhancement of CREB oncogenic signalling. Check the datasheet of any product for its validated reactivity.
Other members of the insulin-like growth factor-binding protein family with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P24593; product specifications from Assay Genie datasheets.